Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

204
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
204
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

130
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
130
Community Based Intervention01:30

Community Based Intervention

227
Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
227
Types of Reports III: Telephone and Verbal Reports01:26

Types of Reports III: Telephone and Verbal Reports

932
Telephone and Verbal Reports in healthcare settings are two communication methods for conveying therapeutic instructions from healthcare providers to nurses or other healthcare staff.
Here's an overview of each type:
Telephone Orders
932
Conduct Disorder01:28

Conduct Disorder

396
Conduct disorder is a complex mental health diagnosis characterized by a repetitive and persistent pattern of behavior that violates societal norms, the rights of others, or age-appropriate rules. The diagnostic criteria for conduct disorder require the presence of at least three problematic behaviors within the past 12 months, with at least one occurring in the past six months. These behaviors are grouped into four categories: aggression toward people and animals; destruction of property;...
396
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Building Community Capacity in Mental Health: What Leaders Can Do.

Healthcare quarterly (Toronto, Ont.)·2025
Same author

Expanding SCINTIX Biology-Guided Radiotherapy Beyond Lung and Bone: A Planning Feasibility and Dosimetric Study on the RefleXion X1 System.

Technology in cancer research & treatment·2025
Same author

Governance of mental healthcare: Fragmented accountability.

Social science & medicine (1982)·2020
Same author

Barriers to Brain Stimulation Therapies for Treatment-Resistant Depression: Beyond Cost Effectiveness.

Canadian journal of psychiatry. Revue canadienne de psychiatrie·2019
Same author

Magnetic seizure therapy (MST) for major depressive disorder.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2019
Same author

Invited commentary: ACCESS Open Minds/Esprits ouverts-A seismic shift in Canadian mental healthcare.

Early intervention in psychiatry·2019

Related Experiment Videos

Community treatment orders in Toronto: the emerging data.

Alison M Hunt1, Angela da Silva, Steve Lurie

  • 1CTO Program, Canadian Mental Health Association, Toronto, Ontario. ahunt@cmha-toronto.net

Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|November 21, 2007
PubMed
Summary
This summary is machine-generated.

Community Treatment Orders (CTOs) in Toronto helped individuals historically refusing services engage with treatment, showing reduced hospital use. Further research should broaden outcome measures for CTO effectiveness.

Related Experiment Videos

Area of Science:

  • Psychiatry
  • Health Services Research
  • Public Health Policy

Background:

  • Community Treatment Orders (CTOs) are legal mechanisms used to manage individuals with severe mental illness who may resist treatment.
  • Evaluating the impact of CTOs on patient engagement and healthcare utilization is crucial for optimizing mental health services.

Purpose of the Study:

  • To compare individuals on CTOs with those not on CTOs regarding sociodemographic and clinical factors.
  • To assess differences in hospital use and continued engagement with health services post-case management program exit.
  • To analyze reductions in hospital stay pre- and post-program admission between the two groups.

Main Methods:

  • Utilized descriptive statistics and significance testing (chi-square, t-tests) on administrative data.
  • Compared hospital use metrics, including cumulative days in hospital and admission rates.
  • Analyzed patient exit outcomes and ongoing support structures.

Main Results:

  • Sociodemographic and clinical variables were statistically similar between CTO and non-CTO groups.
  • The CTO group demonstrated significantly greater reductions in cumulative hospital days and admissions post-admission.
  • Individuals on CTOs were more likely to exit the program sooner and continue with medical supervision, though less likely to exit with intensive support.

Conclusions:

  • CTOs appear effective in Toronto for engaging individuals who historically refused services, despite potential regression to the mean in hospitalization reductions.
  • The study highlights the need for broader operational measures to assess CTO outcomes.
  • Findings suggest CTOs facilitate sustained engagement with treatment and support services.